NO834387L - Fremgangsmaate ved fremstilling av terapeutisk virksomme glycinforbindelser - Google Patents

Fremgangsmaate ved fremstilling av terapeutisk virksomme glycinforbindelser

Info

Publication number
NO834387L
NO834387L NO834387A NO834387A NO834387L NO 834387 L NO834387 L NO 834387L NO 834387 A NO834387 A NO 834387A NO 834387 A NO834387 A NO 834387A NO 834387 L NO834387 L NO 834387L
Authority
NO
Norway
Prior art keywords
glycine
ethoxycarbonyl
alanyl
alkyl
phenylpropyl
Prior art date
Application number
NO834387A
Other languages
English (en)
Norwegian (no)
Inventor
Fu-Chih Huang
Howard Jones
Wan-Kit Chan
Original Assignee
Usv Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Usv Pharma Corp filed Critical Usv Pharma Corp
Publication of NO834387L publication Critical patent/NO834387L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C241/00Preparation of compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • C07C241/02Preparation of hydrazines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/15Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C243/00Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • C07C243/24Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids
    • C07C243/26Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C243/34Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of a carbon skeleton further substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/80Antihypertensive peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Earth Drilling (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO834387A 1982-11-29 1983-11-29 Fremgangsmaate ved fremstilling av terapeutisk virksomme glycinforbindelser NO834387L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/445,117 US4482544A (en) 1982-11-29 1982-11-29 Compounds for treating hypertension

Publications (1)

Publication Number Publication Date
NO834387L true NO834387L (no) 1984-05-30

Family

ID=23767670

Family Applications (1)

Application Number Title Priority Date Filing Date
NO834387A NO834387L (no) 1982-11-29 1983-11-29 Fremgangsmaate ved fremstilling av terapeutisk virksomme glycinforbindelser

Country Status (15)

Country Link
US (1) US4482544A (de)
EP (1) EP0112511B1 (de)
JP (1) JPS59108752A (de)
KR (1) KR840007563A (de)
AT (1) ATE46172T1 (de)
AU (1) AU2176183A (de)
CA (1) CA1249394A (de)
DE (1) DE3380517D1 (de)
ES (1) ES8507472A1 (de)
FI (1) FI834362A7 (de)
IL (1) IL70342A0 (de)
NO (1) NO834387L (de)
NZ (1) NZ206433A (de)
PH (1) PH19870A (de)
ZA (1) ZA838855B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4666906A (en) * 1983-03-16 1987-05-19 Usv Pharmaceutical Corporation Compounds for treating hypertension
US4596791A (en) * 1983-03-16 1986-06-24 Usv Pharmaceutical Corp. Compounds for treating hypertension
AU2859984A (en) * 1983-05-23 1984-11-29 Usv Pharmaceutical Corp. Compounds for treating hypertension
EP0137746A3 (de) * 1983-09-22 1986-01-08 FISONS plc Stickstoffhaltige substituierte Inhibitoren vom Angiotensin-Umwandlungs-Enzym
EP0183398B1 (de) * 1984-11-30 1989-04-12 FISONS plc Inhibitoren für Angiotensin umwandelndes Enzym, deren Herstellung und Verwendung als Pharmazeutika
SE8803847A0 (sv) * 1988-10-27 1990-04-28 Kabigen Ab Neuromodulerande peptid
EP0845438B1 (de) * 1996-11-28 2001-09-19 Kurita Water Industries Ltd. Sauerstoffentfernungsmittel als Verbindung für die Behandlung von Kesselsteinspeisewasser

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL58849A (en) * 1978-12-11 1983-03-31 Merck & Co Inc Carboxyalkyl dipeptides and derivatives thereof,their preparation and pharmaceutical compositions containing them
US4820729A (en) * 1981-03-30 1989-04-11 Rorer Pharmaceutical Corporation N-substituted-amido-amino acids
AU556932B2 (en) * 1981-03-30 1986-11-27 Usv Pharmaceutical Corp. Dipetide with heterocyclic groiup
FI841052A7 (fi) * 1983-03-16 1984-09-17 Usv Pharma Corp Foereningar foer behandling av blodtryckssjukdomar.

Also Published As

Publication number Publication date
DE3380517D1 (en) 1989-10-12
PH19870A (en) 1986-08-13
FI834362A0 (fi) 1983-11-29
US4482544A (en) 1984-11-13
ES527854A0 (es) 1985-10-01
EP0112511A2 (de) 1984-07-04
IL70342A0 (en) 1984-02-29
EP0112511B1 (de) 1989-09-06
ATE46172T1 (de) 1989-09-15
FI834362L (fi) 1984-05-30
AU2176183A (en) 1984-06-07
EP0112511A3 (en) 1985-11-13
NZ206433A (en) 1986-07-11
KR840007563A (ko) 1984-12-08
JPS59108752A (ja) 1984-06-23
ZA838855B (en) 1984-07-25
ES8507472A1 (es) 1985-10-01
CA1249394A (en) 1989-01-24
FI834362A7 (fi) 1984-05-30

Similar Documents

Publication Publication Date Title
AU743881B2 (en) Indole derivatives as inhibitors or factor Xa
KR100337271B1 (ko) 항혈전제
US4350704A (en) Substituted acyl derivatives of octahydro-1H-indole-2-carboxylic acids
US4496542A (en) N-substituted-amido-amino acids
FI78690C (fi) Foerfarande foer framstaellning av terapeutiskt verkande substituerade acylderivat av 1,2,3,4- tetrahydroisokinolin-3-karboxylsyror.
US4626545A (en) Amino acid derivatives as enzyme inhibitors
NO314406B1 (no) Nye peptidderivater, farmasöytisk preparat inneholdende slike derivater, deres anvendelse, fremgangsmåter for deres fremstilling, ogmellomprodukter
IE52553B1 (en) Carboxyalkyl amino acid derivatives of various substituted prolines
US5852051A (en) Dipeptide p-amidinobenzylamides with N-terminal sulfonyl or aminosulfonyl radicals
US4599325A (en) Substituted tyrosyl alanine dipeptide amides
IE68045B1 (en) Renin inhibitors
NO820903L (no) Fremgangsmaate ved fremstilling av amido-aminosyrer.
US4425355A (en) Substituted acyl derivatives of chair form of octahydro-1H-indole-2-carboxylic acids
KR930007431B1 (ko) 경구용 활성 레닌 억제제
AU2007327959B2 (en) Urea and sulfamide derivatives as tafia inhibitors
NO834387L (no) Fremgangsmaate ved fremstilling av terapeutisk virksomme glycinforbindelser
NO840102L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive hydroxylaminoeddiksyrederivater
US4500713A (en) Therapeutic dipeptides
US4559340A (en) Antihypertensive agents
EP0121830A2 (de) Substituierte Dipeptide als Antihypertensiva
EP0127124A2 (de) Verbindungen zur Behandlung von hohem Blutdruck
JPH0247480B2 (de)
JPH0448800B2 (de)
US4160835A (en) Antihypertensive compositions containing an arylsubstituted alanine and a phenyl hydrazinopropionic acid
RU2166503C2 (ru) Производные тиазола, способ их получения, фармацевтическая композиция на их основе и промежуточное соединение